Role Of Matra Basti Of Varun Taila Through Anus And Kanchnar Guggulu Orally in Vatasthleela (BPH)

CLINICAL EVALUATION OF MATRA BASTI OF VARUN TAILA AND KANCHNAR GUGGULU IN VATASTHEELA (BPH)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029404

Enrollment

Registered

2020-11-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Kanchnar Guggulu 500 mg orally: Kanchnar Guggulu 500 mg orally two times a day with luke warm water for 3 months Intervention2: Varun Taila Matra Basti 72 ml by rectal route: Varun Tail

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of BPH along with lower urinary tract symptoms. 2.Age group between 50 â?? 80 years age. 3.Grade 1 and 2 Prostate enlargement.

Exclusion criteria

Exclusion criteria: Diagnosed case of 1.Diabetes mellitus 2.Stricture urethra 3.Prostate carcinoma 4.Idiopathic bladder neck obstruction 5.Bladder neck hypertrophy 6.Renal failure 7.Prostate calculi 8.Neurogenic bladder

Design outcomes

Primary

Measure	Time frame
Relief in the signs such as Enlargement of Prostate and symtoms like increased frequency of micturition in day and night time of vatashteela (BPH)Timepoint: 12 weeks	—

Secondary

Measure	Time frame
Relief in the signs such as Enlargement of Prostate and symtoms like increased frequency of micturition in day and night time of vatashteela (BPH)Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDR KAINAT ANSARI

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar

kaynatansari4@gmail.com8077191963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026